Genzyme posts quarterly profit vs loss
447460
Biotechnology company Genzyme Corp   reported a fourth-quarter profit on Wednesday,  reversing a year-earlier loss, as sales of its drugs for rare  diseases increased.
86092
Gilead Sciences Inc. GILD.O on  Thursday reported higher quarterly net profit on increased  sales of its HIV drugs.
304071
Biogen releases its third-quarter financial results.
18221
Genzyme has agreed to pay at least $325 million to win the hotly contested rights to a potentially powerful cholesterol-lowering drug.
442537
Gilead Sciences Inc posted a third-quarter profit that topped Wall Street targets on Thursday, on sales of drugs that fight the virus that causes AIDS, compared with a year-ago net loss due to acquisition- related costs.
757242
OfficeMax Inc  posted a  better-than-expected quarterly profit on Tuesday, helped by  lower expenses and improved margins.
601186
Business software maker Novell Inc.   posted a preliminary quarterly profit on Tuesday,  bouncing back from a year-earlier loss when it took a $38  million restructuring charge.
565107
Biopharmaceutical company ImClone Systems Inc. said Thursday that it swung to a profit in the third-quarter from a year-ago loss due to sales of colorectal cancer drug Erbitux.
249097
Drugstore chain Rite Aid Corp. RAD.N  on Thursday reported a quarterly profit, reversing a year-ago  loss, on strong cash flow and a reduction in inventory-related  expense.
434445
Amgen  reported on Thursday  that its fourth-quarter profit edged higher as cost cutting  helped offset declining sales of its anemia drugs that have  been hit with safety concerns and new restrictions on their use  and insurance reimbursements.
6470
Wyeth WYE.N on Wednesday reported a  third-quarter profit, reversing a loss in the year-ago period,  when it took a $2 billion charge for liabilities from its  recalled "fen-phen" diet medicines.
607613
Genzyme Corp. said it completed its $345 million acquisition of Bioenvision Inc. despite complaints by some Bioenvision shareholders the price the Cambridge biotech offered was too low. Genzyme initially tried to take control of the New York biotech through a tender offer, but managed to acquire only 22 percent of shares that way. Bioenvision then tried to persuade a majority ...
595740
Schering-Plough Corp. swung to a profit in the third quarter from a loss a year ago, even as sales decline slightly in the period.
369749
Amgen  reported on Thursday that its fourth-quarter profit edged higher as cost cutting helped offset sharply declining sales of its anemia drugs that have been hit with safety concerns and new restrictions on use and insurance reimbursements.
301333
NEW YORK  - Genzyme Corp. announced  Wednesday that its drug Clolar has been approved by the U.S.  Food and Drug Administration (FDA) for the treatment of  children with difficult or relapsed acute lymphoblastic  leukemia (ALL).
594161
Genzyme announces positive study results with a recently acquired drug.
131156
LONDON (CBS.MW) -- The US Food and Drug Administration has approved a Genzyme Corp. (GENZ) cancer drug for treating a type of childhood leukemia after other therapies have failed.